Genmab — April 2017

[Solsen]

Det der er overset er, at dara faktisk har bedre monoeffekt end PD1 og PD-L1 i mono....

[Solsen]

Så ikke kun kombi med checkpoint kan være interessante.

[Solsen]

R&D dagen hos JNJ bliver superspændende !

[Helge_LarsenPI-redaktør]

Teknisk analyse Genmab og Novo: https://play.borsen.dk/social/58fdabdd45628ff817201c3f

[JohnW]

Det er ikke den store glæde Genmab-aktien får af
festen i dag.

[bibob]

Dara - Nivolumab i solide tumorer forventet start 28 april. https://clinicaltrials.gov/ct2/show/NCT03098550?term=daratumumab+nsclc&rank=2

[E_L]

Immunotherapy-pioneer James Allison, general article : https://www.technologyreview.com/s/604086/immunotherapy-pioneer-james-allison-has-unfinished-business-with-cancer/

[BobTheThird]

@JohnW - nææh ikke rigtigt, men stadig en grøn/plus dag og det kan man jo ikke kimse af.

[jkj]

hvad dato er R&D solsen

[JohnW]

Så sandt @BobTheThird, så sandt.

[GeorgeBest]

JNJ Pharmaceutical Business Review 17. maj

[Sukkeralf]

Samme dag ASCO abstracs frigives

[bibob]

Skriv dagen i kalenderen.. det bliver spændende.

[E_L]

Haven't heard anything about the 2nd NICE Committee meeting on Apr 20, thought those meetings were public. Looks like we have to wait until July for the small chance they will surprise us with a UK approval. https://www.nice.org.uk/guidance/indevelopment/gid-ta10076

[bibob]

Er der nogen der har adgang og kan se om Dara blev godkendt af EMA. ? http://medwatch.dk/secure/Medicinal___Biotek/article9526585.ece?utm_campaign=Middag&utm_content=2017-04-24 12%3A16%3A13&utm_medium=top&utm_source=Feed

[E_L]

We are waiting for the European Comission now, who should approve based on the positive recommendation EMA already gave -if i am correc
t?

[bibob]

Yes that`s right. It should come this week . I guess Friday.

[bibob]

LUK : 1310.

[Bulder]

@ gentogen: dit link ang dara pom i går kl 10:51 skulle vist have været dette her https://www.youtube.com/watch?v=-6M0a51-xyw

[Bulder]

Men rigtigt, han er meget begejstret for dara-pom